These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 775438)

  • 21. [Pre- and perinatal use of drugs].
    Ankermann H
    Z Arztl Fortbild (Jena); 1970 Nov; 64(22):1125-9. PubMed ID: 5505103
    [No Abstract]   [Full Text] [Related]  

  • 22. [Undesirable effects of drug interaction in everyday medical practice. Round-table conference II].
    Pol Tyg Lek; 1981 Sep; 36(36):1391-6. PubMed ID: 7329856
    [No Abstract]   [Full Text] [Related]  

  • 23. [Study of the adverse effects of drugs].
    Jávor T; Simon K; Gógl A
    Orv Hetil; 1974 Aug; 115(33):1923-6. PubMed ID: 4846484
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pharmacotherapy for reduced activity of microsomal liver enzymes (review of the literature)].
    Chekman IS; Grinevich AI
    Vrach Delo; 1988 Jan; (1):24-8. PubMed ID: 3284200
    [No Abstract]   [Full Text] [Related]  

  • 25. [Adverse effects of drugs. 15. Control of side effects by the adrenal glands. 1].
    Tamura T
    Kango; 1974 Apr; 26(4):128-9. PubMed ID: 4495506
    [No Abstract]   [Full Text] [Related]  

  • 26. [Adverse effects of drugs. 14. Control of side effects by the thymus gland].
    Tamura T
    Kango; 1974 Mar; 26(3):98-9. PubMed ID: 4495484
    [No Abstract]   [Full Text] [Related]  

  • 27. [Problems of drug research].
    Büchi J
    Pharm Weekbl; 1968 Apr; 103(17):429-52. PubMed ID: 4874723
    [No Abstract]   [Full Text] [Related]  

  • 28. [Pharmacokinetics].
    Cahen R
    Eur J Toxicol Hyg Environ; 1972; Suppl 3():67-80. PubMed ID: 4157455
    [No Abstract]   [Full Text] [Related]  

  • 29. [Metabolism and toxicity of drugs used during pregnancy and perinatal period].
    Prandota J; Iwańczak F
    Pediatr Pol; 1980 Apr; 55(4):517-24. PubMed ID: 6997824
    [No Abstract]   [Full Text] [Related]  

  • 30. [Unwanted and toxic drug effects].
    Dominok GW; Terhaag B
    Z Arztl Fortbild (Jena); 1984; 78(23):973-6. PubMed ID: 6528640
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical and clinical considerations of new drug investigation.
    Sanen FJ
    Int J Clin Pharmacol; 1973 Apr; 7(2):190-7. PubMed ID: 4581341
    [No Abstract]   [Full Text] [Related]  

  • 32. Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry.
    Ma S; Subramanian R
    J Mass Spectrom; 2006 Sep; 41(9):1121-39. PubMed ID: 16967439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1984 Stokinger lecture. Some questions and opinions on issues in toxicology and risk assessment.
    Weil CS
    Am Ind Hyg Assoc J; 1984 Oct; 45(10):663-70. PubMed ID: 6496314
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of metabolic activation in drug toxicity.
    Hinson JA; Pumford NR; Nelson SD
    Drug Metab Rev; 1994; 26(1-2):395-412. PubMed ID: 7521825
    [No Abstract]   [Full Text] [Related]  

  • 35. [Preclinical evaluation of new drugs].
    Berde B
    Munch Med Wochenschr; 1972 Sep; 114(38):1591-4. PubMed ID: 4678408
    [No Abstract]   [Full Text] [Related]  

  • 36. Why the elderly are so vulnerable to drug reactions.
    Westfall LK; Pavlis RW
    RN; 1987 Nov; 50(11):39-43. PubMed ID: 3685798
    [No Abstract]   [Full Text] [Related]  

  • 37. [Risk of pharmacotherapy from the viewpoint of the internist].
    Mähr G
    Z Arztl Fortbild (Jena); 1984; 78(23):989-92. PubMed ID: 6396975
    [No Abstract]   [Full Text] [Related]  

  • 38. Food and drug administration statement of problem.
    Perez MK
    J Toxicol Environ Health; 1977 Mar; 2(4):727-30. PubMed ID: 558337
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacological and toxicological significance of the stereochemistry of drug disposition.
    Caldwell J; Winter SM; Hutt AJ
    Xenobiotica; 1988 Jan; 18 Suppl 1():59-70. PubMed ID: 3344590
    [No Abstract]   [Full Text] [Related]  

  • 40. Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions.
    Kumar S; Kassahun K; Tschirret-Guth RA; Mitra K; Baillie TA
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):43-52. PubMed ID: 18175266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.